Financial giants have made a conspicuous bearish move on Teva Pharmaceutical Indus. Our analysis of options history for Teva Pharmaceutical Indus (NYSE:TEVA) revealed 8 unusual trades. Delving ...

Financial giants have made a conspicuous bearish move on Teva Pharmaceutical Indus. Our analysis of options history for Teva Pharmaceutical Indus TEVA revealed 8 unusual trades. Delving into the ...

Deep-pocketed investors have adopted a bullish approach towards Teva Pharmaceutical Indus TEVA, and it's something market players shouldn't ignore. Our tracking of public options records at ...

Financial giants have made a conspicuous bullish move on Teva Pharmaceutical Indus. Our analysis of options history for Teva Pharmaceutical Indus (NYSE:TEVA) revealed 8 unusual trades. Delving ...

MUMBAI, India and WALTHAM, Mass., March 9, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...

March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...

In his March 17 op-ed, “We should stop acting as if Big Pharma is the big villain in American health care,” Erick Erickson writes, “The government cannot provide clarity or direction for ...

Shares of Trent, Sun Pharma, ICICI Bank, Bharti Airtel and BPCL topped the list of gainers among Nifty 50 pack, while IndusInd, Infosys, Bajaj Finserv, M&M and Wipro depreciated. Realty stocks ...

WASHINGTON, March 24 (Reuters) - U.S. President Donald Trump said on Monday he will in the very near future announce tariffs on automobiles, aluminum and pharmaceuticals. Speaking to reporters at ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

Hampton was appointed by the Justice Department in 2019 to represent the financial interests of victims in the Purdue Pharma bankruptcy case. For two years, he served on a committee of creditors.